Close
Smartlab Europe
Achema middle east

content

Novartis announces FDA approval of Gilenya as the first disease-modifying therapy for pediatric relapsing multiple sclerosis

Novartis announced that the US FDA has approved Gilenya® (fingolimod) for the treatment of children and adolescents 10 to less than 18 years of...

Take a Closer Look at the Pharma Logistics Compliance Report!

This whitepaper covers the latest pharmaceutical logistics regulatory developments around the globe such as FMD, MHRA, ICH Q12, PACMP, GMP, DSCSA and more!. ...

ChargePoint Technology Launches First-of-its-kind Smart Monitoring Technology at ACHEMA 2018

Powder containment and aseptic transfer valve specialist, ChargePoint Technology, has launched a unique Smart monitoring hub to support efficiency and safety within chemical and...

Protagen AG collaborates with UCSF to study better immuno-profiling of cancer patients receiving immunotherapy

Protagen AG has announced the start of a collaboration with the University of California, San Francisco (UCSF) to utilize Protagen’s SeroTag® technology to investigate...

CRF Health’s eCOA Solution Selected for Large-Scale Insomnia Study by Innovative European Pharmaceutical Company

CRF Health, the leading provider of patient-centered eSource for the life sciences industry, announced that its electronic Clinical Outcome Assessment (eCOA) solutions have been...

Tjoapack invests in blistering capabilities

Global contract packaging organisation (CPO), Tjoapack has invested in its blistering capacity, adding a new line that will be equipped with late-stage customisation printing...

Ardena acquires Syntagon and strengthens API offering

Contract development and manufacturing organisation (CDMO) Ardena has acquired Syntagon, a leading contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients. ...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »